OLMA NASDAQ
Olema Pharmaceuticals, Inc.
1W: -2.2%
1M: -29.9%
3M: -33.7%
YTD: -58.7%
1Y: +134.3%
3Y: +84.3%
5Y: -62.8%
$10.45
+0.49 (+4.92%)
Pre-Market: $10.48 (+0.04, +0.33%)
Weekly Expected Move ±10.1%
$8
$9
$10
$11
$12
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q1 2026243
Institutions Holding
+28 vs prior
146.4%
Ownership
-98.75%
41
New
69
Increased
106
Reduced
62
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-03-04 | Mitchell Shawnte | officer: chief legal officer | S-Sale | 233 | $24.69 | $6K | Filing |
| 2026-03-04 | Mitchell Shawnte | officer: chief legal officer | S-Sale | 24,767 | $24.25 | $601K | Filing |
| 2026-03-03 | Mitchell Shawnte | officer: chief legal officer | S-Sale | 15,000 | $23.01 | $345K | Filing |
| 2026-02-02 | Austin Sasha Lu | officer: vp of finance and controller | A-Grant/Award | 11,700 | $— | $0 | Filing |
| 2026-01-20 | Harmon Cyrus | director | S-Sale | 10,000 | $26.88 | $269K | Filing |
| 2026-01-15 | Kovacs Shane William Charles | officer: ch. operating & financial off. | S-Sale | 100,000 | $28.73 | $2.9M | Filing |
| 2026-01-14 | Harmon Cyrus | director | S-Sale | 3,489 | $29.12 | $102K | Filing |
| 2026-01-14 | Myles David C. | officer: ch. discov. & non-clin dev off | S-Sale | 14,997 | $28.60 | $429K | Filing |
| 2026-01-14 | Myles David C. | officer: ch. discov. & non-clin dev off | S-Sale | 35,003 | $28.99 | $1.0M | Filing |
| 2026-01-13 | Kovacs Shane William Charles | officer: ch. operating & financial off. | S-Sale | 3,822 | $28.01 | $107K | Filing |
| 2026-01-13 | Myles David C. | officer: ch. discov. & non-clin dev off | S-Sale | 49,800 | $27.60 | $1.4M | Filing |
| 2026-01-13 | Myles David C. | officer: ch. discov. & non-clin dev off | S-Sale | 200 | $28.49 | $6K | Filing |
| 2026-01-12 | Myles David C. | officer: ch. discov. & non-clin dev off | S-Sale | 10,000 | $28.34 | $283K | Filing |
| 2025-12-26 | Bohen Sean | officer: president and ceo | G-Gift | 8,500 | $— | $0 | Filing |
| 2025-12-23 | Zojwalla Naseem | officer: chief medical officer | S-Sale | 99,509 | $27.66 | $2.8M | Filing |
| 2025-12-22 | Zojwalla Naseem | officer: chief medical officer | S-Sale | 100,000 | $28.04 | $2.8M | Filing |
| 2025-12-22 | Harmon Cyrus | director | S-Sale | 2,881 | $28.53 | $82K | Filing |
| 2025-12-19 | Myles David C. | officer: ch. discov. & non-clin dev off | S-Sale | 1,225 | $28.08 | $34K | Filing |
| 2025-12-19 | Myles David C. | officer: ch. discov. & non-clin dev off | S-Sale | 43,729 | $30.40 | $1.3M | Filing |
| 2025-12-19 | Myles David C. | officer: ch. discov. & non-clin dev off | S-Sale | 6,046 | $31.39 | $190K | Filing |
| 2025-12-19 | Myles David C. | officer: ch. discov. & non-clin dev off | G-Gift | 9,000 | $— | $0 | Filing |
| 2025-12-19 | Zojwalla Naseem | officer: chief medical officer | S-Sale | 57,079 | $28.03 | $1.6M | Filing |
| 2025-12-19 | Zojwalla Naseem | officer: chief medical officer | S-Sale | 12,921 | $28.93 | $374K | Filing |
| 2025-12-19 | CLARK IAN T | director | S-Sale | 41,840 | $30.48 | $1.3M | Filing |
| 2025-12-19 | CLARK IAN T | director | S-Sale | 29,904 | $28.83 | $862K | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| FMR LLC | 10,386,845 | $155M | +5,363,753 | 2026-03-31 | Filing |
| Paradigm Biocapital Advisors LP | 8,020,576 | $120M | +476,404 | 2026-03-31 | Filing |
| Bain Capital Life Sciences Investors, LL | 7,473,238 | $111M | -1,035,403 | 2026-03-31 | Filing |
| JANUS HENDERSON GROUP PLC | 7,108,488 | $106M | +398,294 | 2026-03-31 | Filing |
| BlackRock, Inc. | 5,652,135 | $84M | +88,875 | 2026-03-31 | Filing |
| Siren, L.L.C. | 4,756,949 | $71M | +1,456,249 | 2026-03-31 | Filing |
| STATE STREET CORP | 3,937,831 | $59M | +2,053,432 | 2026-03-31 | Filing |
| Cormorant Asset Management, LP | 3,900,000 | $58M | +1,150,000 | 2026-03-31 | Filing |
| Logos Global Management LP | 3,208,875 | $48M | — | 2026-03-31 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 3,083,517 | $46M | +3,083,517 | 2026-03-31 | Filing |
| RA CAPITAL MANAGEMENT, L.P. | 2,600,000 | $39M | — | 2026-03-31 | Filing |
| JENNISON ASSOCIATES LLC | 1,822,123 | $27M | +858,126 | 2026-03-31 | Filing |
| Polar Capital Holdings Plc | 1,602,970 | $24M | +222,520 | 2026-03-31 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 1,544,417 | $23M | +286,976 | 2026-03-31 | Filing |
| Defilade Capital Management, L.P. | 1,504,536 | $22M | +269,902 | 2026-03-31 | Filing |
| Woodline Partners LP | 1,482,030 | $22M | +100 | 2026-03-31 | Filing |
| LIGHTSPEED MANAGEMENT COMPANY, L.L.C. | 1,355,299 | $20M | -575,595 | 2026-03-31 | Filing |
| FRANKLIN RESOURCES INC | 1,218,957 | $18M | -1,257,708 | 2026-03-31 | Filing |
| DIMENSIONAL FUND ADVISORS LP | 1,082,434 | $16M | +123,790 | 2026-03-31 | Filing |
| GOLDMAN SACHS GROUP INC | 1,045,589 | $16M | +227,700 | 2026-03-31 | Filing |